http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04283577-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c8bffd30b513a7c8ac7d736fa3ef27f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d78cd2835221849f6a74e6349185819
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-56
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
filingDate 1991-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4dace9ec2f529f408b794af85b10259
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d399812ddcddb9742c960cd49f3e6646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb8b1429c9877a8aa319a49d123cd613
publicationDate 1992-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H04283577-A
titleOfInvention Aryl derivative, its production and pharmaceutical containing its compound to be used for leukotriene-induced disease or symptom
abstract PURPOSE: To obtain a new aryl deriv. which is useful for the treatment for inflammatory or allergic diseases induced by catalytic oxidation of arachidonic acid with 5-lipoxigenase, by coupling specified two kinds of compds. n CONSTITUTION: A compd. expressed by formula I is subjected to coupling reaction with a compd. expressed by formula II in the presence of a base in an inert solvent with addition of a catalyst, preferably at 100°C to obtain the objective compd. expressed by formula III. The compd. expressed by formula III is, for example, 4-[3-(4-(4-fluorobenzyl)phenylthio)phenyl]-4- methoxytetrahydropyran. In formula I, Ar 1 is phenyl, naphthyl, etc.; X 1 is oxy, thio, sulfinyl, etc.; Ar 2 is halogen, hydroxy, etc.; X 2 is oxy, thio, etc. In formula II, R 1 is 1-4C alkyl, 3-4C alkenyl, etc.; R 2 and R 3 may be bonded to form -A 1 -X 3 -A 2 (wherein A 1 , A 2 are 1-3C alkylene and form a 5 to 7-membered ring with the carbon atom bonded; X 3 is oxy, thio, etc. n COPYRIGHT: (C)1992,JPO
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017503012-A
priorityDate 1990-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5312542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414940547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234844011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422386078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9866168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 42.